Clinical safety and efficacy of the first-in-class Rho kinase inhibitor for lowering IOP: netarsudil and the fixed-dose combination of netarsudil and latanoprost “Special consideration for pediatric glaucoma” has been added to your cart. View cart €15.00 Clinical safety and efficacy of the first-in-class Rho kinase inhibitor for lowering IOP: netarsudil and the fixed-dose combination of netarsudil and latanoprost quantity Add to cart Category: Articles Tag: Volume 3 Description Description Authors: Janet B. Serle, Jake Radell Related products Glaucoma and stem cells €15.00 Add to cart Trabecular meshwork cell death in primary open-angle glaucoma €15.00 Add to cart The role of blood flow in glaucoma €15.00 Add to cart Biomarkers in primary open-angle glaucoma €15.00 Add to cart